BioPharmSignal logoBioPharmSignal

Biotech News

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc.Earnings

BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. It will hold its quarterly conference call to discuss the results

Related news

OSUROraSure Technologies, Inc.2026-04-22 20:10 EST

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

OSUROraSure Technologies, Inc.2026-02-09 21:15 EST

OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th

SERASera Prognostics2026-07-29 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

XGNExagen2026-07-21 13:00 EST

Exagen to Announce Second Quarter Financial Results on August 4, 2026

FLGTFulgent Genetics, Inc.2026-07-09 20:05 EST

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

XGNExagen2026-02-24 14:00 EST

Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

FLGTFulgent Genetics, Inc.2026-02-12 12:30 EST

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

MDXHMDxHealth2026-07-30 20:00 EST

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13

LUCDLucid Diagnostics2026-07-30 12:30 EST

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

BRLIBio-Reference Laboratories2026-07-27 20:05 EST

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

View all latest news

OraSure Technologies, Inc.

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient. Rapid-Test Portfolio The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries...

Recent company news

OSUROraSure Technologies, Inc.2026-08-05 20:05 EST

OraSure Announces Second Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OSUROraSure Technologies, Inc.2026-07-21 20:30 EST

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

OSUROraSure Technologies, Inc.2026-06-11 12:00 EST

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OSUROraSure Technologies, Inc.2026-05-06 20:05 EST

OraSure Announces First Quarter 2026 Financial Results

Stock data

Close
4.00 USD
Market cap
275.39M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States